Amwell to Report Second Quarter 2023 Operating Results and Host Conference Call on Wed., Aug. 2, 2023

Rhea-AI Summary

Amwell (NYSE: AMWL) will report its Q2 2023 operating results on Aug. 2, 2023. A live conference call and webcast will be held at 5 p.m. ET to review the results and provide a business update. A replay will be available for on-demand listening.

BOSTON--(BUSINESS WIRE)-- Amwell® (NYSE: AMWL), a leader in hybrid health care enablement, today announced it will report its second quarter 2023 operating results on Wed., Aug. 2, 2023. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. Eastern Time to review the company's operating results and provide a general business update.

A live audio webcast can be accessed by visiting the Investors section of the company's website at investors.amwell.com. Alternatively, please call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call. The conference ID number for the live call will be 7830032. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Amwell

Amwell provides a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. The company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the hybrid care of more than 55 health plans, which collectively represent more than 90 million covered lives, and many of the nation’s largest health systems, representing over 2,000 hospitals, have access to Amwell solutions. For more information, please visit https://business.amwell.com/.

American Well, Amwell, Converge, SilverCloud, Conversa and Carepoint are registered trademarks or trademarks of American Well Corporation in the United States and other countries. All other trademarks used herein are the property of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in our most recent form 10-K filed with the SEC. These risks are not exhaustive. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Further information on factors that could cause actual results to differ materially from the results anticipated by our forward-looking statements is included in the reports we have filed or will file with the Securities and Exchange Commission. These filings, when available, are available on the investor relations section of our website at investors.amwell.com and on the SEC’s website at www.sec.gov.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230719252293/en/

Investor Contact:

Sue Dooley

Sue.dooley@amwell.com

415-602-9167



Press Contact:

Angela Vogen

Press@amwell.com

Source: Amwell

FAQ

When will Amwell report its Q2 2023 operating results?

Amwell will report its Q2 2023 operating results on Aug. 2, 2023.

What time will the conference call and webcast be held?

The conference call and webcast will be held at 5 p.m. Eastern Time.

How can I access the live audio webcast?

You can access the live audio webcast by visiting the Investors section of Amwell's website at investors.amwell.com.

What are the phone numbers to listen to the live conference call?

To listen to the live conference call, you can call (888) 510-2008 (U.S.) or (646) 960-0306 (International).

What is the conference ID number for the live call?

The conference ID number for the live call is 7830032.

Will there be a replay of the call?

Yes, a replay of the call will be available via webcast for on-demand listening shortly after the completion of the call.

How long will the replay be available?

The replay will remain available for approximately 90 days.